I don't know what this list of emails reveals other than the participants of an online meeting. Maybe they're the key players involved at either silencing Brook Jackson or hiding the fraud of Pfizer's Phase III trials.

Ventavia Research Group - you're going down!

Your companies have ruined so many lives. I hope you all go to freaking jail! pic.twitter.com/hWWRRCHysV

— Brook Jackson 💜 (@IamBrookJackson) December 27, 2022

This might help to clarify her intent of the post. 

com·plic·it adj - helping to commit a crime or do wrong in some way "He was complicit in the cover-up." -Marriam Webster

Share what you know: clinicaltrialwhistleblower@proton.me @pfizer @ICONplc @advarra @FDACBER @TheJusticeDept pic.twitter.com/cAYEyScVFJ

— Brook Jackson 💜 (@IamBrookJackson) December 27, 2022

Ventavia is Jackson's former employer.

POOR LABORATORY MANAGEMENT 

On its website Ventavia calls itself the largest privately owned clinical research company in Texas and lists many awards it has won for its contract work.2 But Jackson has told The BMJ that, during the two weeks she was employed at Ventavia in September 2020, she repeatedly informed her superiors of poor laboratory management, patient safety concerns, and data integrity issues. Jackson was a trained clinical trial auditor who previously held a director of operations position and came to Ventavia with more than 15 years’ experience in clinical research coordination and management. Exasperated that Ventavia was not dealing with the problems, Jackson documented several matters late one night, taking photos on her mobile phone. One photo, provided to The BMJ, showed needles discarded in a plastic biohazard bag instead of a sharps container box. Another showed vaccine packaging materials with trial participants’ identification numbers written on them left out in the open, potentially unblinding participants. Ventavia executives later questioned Jackson for taking the photos.

Early and inadvertent unblinding may have occurred on a far wider scale. According to the trial’s design, unblinded staff were responsible for preparing and administering the study drug (Pfizer’s vaccine or a placebo). This was to be done to preserve the blinding of trial participants and all other site staff, including the principal investigator. However, at Ventavia, Jackson told The BMJ that drug assignment confirmation printouts were being left in participants’ charts, accessible to blinded personnel. As a corrective action taken in September, two months into trial recruitment and with around 1000 participants already enrolled, quality assurance checklists were updated with instructions for staff to remove drug assignments from charts.